LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.19 | 27.76 | 832 | 1863 | 0.4466 | 0.7512 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.19 | 27.76 | 104 | 1863 | 0.0558 | 0.2432 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.19 | 27.76 | 1286 | 1863 | 0.6902 | 0.8815 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 30.90 | 27.76 | 830 | 2032 | 0.4084 | 0.7308 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 30.90 | 27.76 | 863 | 2032 | 0.4246 | 0.7417 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 30.90 | 27.76 | 99 | 2032 | 0.0487 | 0.2279 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 30.90 | 27.76 | 1281 | 2032 | 0.6303 | 0.8564 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 32.60 | 27.76 | 831 | 2235 | 0.3717 | 0.7106 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 32.60 | 27.76 | 854 | 2235 | 0.3820 | 0.7180 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 32.60 | 27.76 | 112 | 2235 | 0.0501 | 0.2465 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 32.60 | 27.76 | 1291 | 2235 | 0.5774 | 0.8338 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 34.30 | 27.76 | 841 | 2449 | 0.3433 | 0.6951 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 34.30 | 27.76 | 864 | 2449 | 0.3527 | 0.7022 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 34.30 | 27.76 | 115 | 2449 | 0.0469 | 0.2460 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 34.30 | 27.76 | 1344 | 2449 | 0.5486 | 0.8226 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.01 | 27.76 | 890 | 2662 | 0.3342 | 0.6933 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.01 | 27.76 | 905 | 2662 | 0.3399 | 0.6976 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.01 | 27.76 | 135 | 2662 | 0.0507 | 0.2716 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 36.01 | 27.76 | 1362 | 2662 | 0.5115 | 0.8064 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 37.71 | 27.76 | 837 | 2877 | 0.2909 | 0.6632 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 37.71 | 27.76 | 847 | 2877 | 0.2943 | 0.6661 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 37.71 | 27.76 | 142 | 2877 | 0.0493 | 0.2761 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 37.71 | 27.76 | 1329 | 2877 | 0.4618 | 0.7821 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 39.41 | 27.76 | 897 | 3105 | 0.2888 | 0.6664 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 39.41 | 27.76 | 913 | 3105 | 0.2940 | 0.6707 | MN20160318_Q01 | D07 |